LYEL
LYEL
NASDAQ · Biotechnology

Lyell Immunopharma Inc

Biotech Stocks Healthcare Stocks
$12.74
+0.22 (+1.76%)
As of Jun 21, 10:21 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 10 83%
Hold 1 8%
Sell 1 8%
Price Target
Analyst Price Target +119.4% upside
Low Target $18.45
Average Target $27.95
High Target $35.39
Current Price $12.74
Current
$12.74
Target
$27.95
$18.45 $27.95 avg $35.39
Scenario Analysis
Bear Case
$18.45
44.8%
Low target
Base Case
$27.95
+119.4%
Avg target
Bull Case
$35.39
+177.8%
High target
Risk/Reward
4.0x
Highly favorable
Price in Context
52-Week High
$45.00
-71.7% from high
52-Week Low
$8.46
+50.6% from low
Target vs 52W High
$27.95
-37.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.7%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +189.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -7.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -65.2%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.8%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -45.0%